human | Q5 |
P2038 | ResearchGate profile ID | Argyrios_Ziogas |
P108 | employer | University of California, Irvine | Q868421 |
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
Q45978346 | A comparison study of clinicopathologic characteristics of Southern California Asian American Non-small Cell Lung Cancer (NSCLC) patients by smoking status. |
Q33747778 | A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. |
Q29417084 | A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. |
Q37192589 | A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication |
Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
Q46234252 | A population-based, descriptive analysis of malignant intraductal papillary mucinous neoplasms of the pancreas |
Q40657328 | A resource utilization projection study of EUS. |
Q36946511 | A targeted genetic association study of epithelial ovarian cancer susceptibility |
Q33637973 | A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important |
Q27908547 | A validation method to determine missing years of birth in a cohort study of shipyard workers using social security number |
Q46193621 | Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study |
Q33619769 | Adenomyosis and endometriosis in the California Teachers Study |
Q43663669 | Adherence to treatment guidelines for ovarian cancer as a measure of quality care |
Q24812570 | Adipose tissue levels of organochlorine pesticides and polychlorinated biphenyls and risk of non-Hodgkin's lymphoma |
Q38406780 | Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study |
Q52647897 | Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. |
Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
Q46314406 | An age-dependent interaction between sex and geographical UV index in melanoma risk |
Q46063050 | An inverse association between ovarian cysts and breast cancer in the breast cancer family registry |
Q36831854 | Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome |
Q45948722 | Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. |
Q53379714 | Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status. |
Q46851695 | Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates |
Q37584843 | Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium |
Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
Q30276986 | Assessing the genetic architecture of epithelial ovarian cancer histological subtypes |
Q37684409 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer |
Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
Q33828680 | Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival |
Q24619808 | Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies |
Q46006754 | Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults. |
Q37200998 | Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study |
Q39423088 | Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study |
Q37403674 | Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival |
Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
Q37640500 | Attitudes Toward Cancer Clinical Trial Participation in Young Adults with a History of Cancer and a Healthy College Student Sample: A Preliminary Investigation |
Q46002468 | Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. |
Q39642676 | Breast cancer risk and methylenetetrahydrofolate reductase polymorphism |
Q46138590 | Breast cancer survival and hormone replacement therapy: a cohort analysis |
Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
Q50915196 | Cancer burden in four countries of the Middle East Cancer Consortium (Cyprus; Jordan; Israel; Izmir (Turkey)) with comparison to the United States surveillance; epidemiology and end results program. |
Q33833595 | Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer |
Q38627972 | Cancer risk in different generations of Middle Eastern immigrants to California, 1988-2013. |
Q41745402 | Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer |
Q46778926 | Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases |
Q35782435 | Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer |
Q46525423 | Clinical Implementation of a Breast Cancer Risk Assessment Program in a Multiethnic Patient Population: Which Risk Model to Use? |
Q36009587 | Clinically relevant changes in family history of cancer over time |
Q37657957 | Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer |
Q35668946 | Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk |
Q29417145 | Common variants at 19p13 are associated with susceptibility to ovarian cancer |
Q36255665 | Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer |
Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
Q34342248 | Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk |
Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
Q30745400 | Correlates of vitamin supplement use in the United States: data from the California Teachers Study cohort |
Q37158390 | Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer |
Q44775873 | Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity |
Q55115973 | Diet and predictors of dietary intakes in women with family history of breast and/or ovarian cancer. |
Q36168230 | Diet and risk of ovarian cancer in the California Teachers Study cohort |
Q33805341 | Dietary Risk Factors for Sporadic Creutzfeldt-Jakob Disease: A Confirmatory Case-Control Study |
Q46082238 | Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer |
Q36627299 | Dietary patterns and risk of ovarian cancer in the California Teachers Study cohort |
Q46349072 | Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease |
Q33824208 | ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study |
Q24810775 | Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer |
Q44249326 | Effects of socioeconomic status and treatment disparities in colorectal cancer survival |
Q41868438 | Enhanced Expression of Radiation-induced Leukocyte CDKN1A mRNA in Multiple Primary Breast Cancer Patients: Potential New Marker of Cancer Susceptibility. |
Q28282443 | Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors |
Q53591906 | Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. |
Q24633316 | Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer |
Q36487146 | Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk |
Q57319395 | Erratum: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer |
Q57306046 | Erratum: Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium |
Q36966218 | Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study |
Q35897406 | Evaluation of 30-day hospital readmission after surgery for advanced-stage ovarian cancer in a medicare population |
Q21144976 | Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot" |
Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
Q38845261 | Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk |
Q46629818 | Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q36956156 | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer |
Q39565188 | Gene-environment interactions in renal cell carcinoma |
Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
Q40060942 | Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study |
Q36218993 | Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium |
Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
Q33778612 | Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. |
Q33410700 | Genotype determination for polymorphisms in linkage disequilibrium |
Q28146076 | Germ-line msh6 mutations in colorectal cancer families |
Q21195235 | Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer |
Q45236849 | High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease |
Q40060927 | History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium |
Q41115943 | Human Nail Clippings as a Source of DNA for Genetic Studies |
Q34134850 | Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort |
Q46950052 | Hypertension, diuretics and breast cancer risk |
Q37006170 | Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. |
Q35541663 | Identification of six new susceptibility loci for invasive epithelial ovarian cancer |
Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
Q34470171 | Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival |
Q40249992 | Impact of community disadvantage and air pollution burden on geographic disparities of ovarian cancer survival in California |
Q41757407 | Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California |
Q31101650 | Imputation of missing ages in pedigree data |
Q37684424 | Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration |
Q46301216 | Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: radiotherapy or surgery 1988-1995. |
Q30277784 | Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer |
Q42997447 | Korean ethnicity as compared with white ethnicity is an independent favorable prognostic factor for overall survival in non-small cell lung cancer before and after the oral epidermal growth factor receptor tyrosine kinase inhibitor era. |
Q37725393 | Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome |
Q46219463 | Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study |
Q46196878 | Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis |
Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
Q43793910 | Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status |
Q24618839 | Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X |
Q34097339 | Meat consumption, nonsteroidal anti-inflammatory drug use, and mortality among colorectal cancer patients in the California Teachers Study |
Q36450416 | Meat consumption, ornithine decarboxylase gene polymorphism, and outcomes after colorectal cancer diagnosis |
Q44082151 | Microsatellite instability in Japanese vs European American patients with gastric cancer |
Q36719139 | Microvascular breast reconstruction in the diabetic patient |
Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
Q36551503 | Mortality risk after preoperative versus postoperative chemotherapy and radiotherapy in lymph node-positive rectal cancer |
Q36015876 | Multilevel socioeconomic effects on quality of life in adolescent and young adult survivors of leukemia and lymphoma |
Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
Q46659535 | Negative Valence Life Events Promote Breast Cancer Development |
Q26799669 | Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk |
Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
Q30275832 | No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival |
Q28176257 | Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status |
Q34432899 | Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis |
Q35892049 | Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study |
Q37378287 | Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium |
Q36027025 | Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium |
Q37486444 | Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer |
Q33973395 | Ocular Tonometry and Sporadic Creutzfeldt - Jakob Disease (sCJD): A Confirmatory Case-Control Study |
Q34398269 | Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations |
Q46355918 | Outcomes of bariatric surgery performed at accredited vs nonaccredited centers |
Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
Q46147249 | Physical activity and colon cancer risk among women in the California Teachers Study |
Q40798938 | Pilot study of blood biomarker candidates for detection of pancreatic cancer |
Q45073049 | Polycystic ovary syndrome, oligomenorrhea, and risk of ovarian cancer histotypes: Evidence from the Ovarian Cancer Association Consortium |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q33891803 | Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium |
Q24648412 | Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women |
Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
Q33921008 | Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium |
Q35899433 | Population-based evaluation of adenosquamous carcinoma of the colon and rectum |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q45985998 | Primary signet-ring carcinoma (SRC) of the lung: a population-based epidemiologic study of 262 cases with comparison to adenocarcinoma of the lung. |
Q51667280 | Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity. |
Q46634553 | Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. |
Q45985654 | Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size. |
Q35223068 | Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer |
Q34958895 | Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling |
Q30448634 | R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression |
Q46016968 | Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. |
Q52759419 | Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. |
Q53698034 | Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. |
Q46351229 | Recruitment strategies for cervical cancer prevention study |
Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
Q46060490 | Regional variations in breast cancer among california teachers |
Q39705133 | Residential mobility in the California Teachers Study: implications for geographic differences in disease rates |
Q46338113 | Residential proximity to agricultural pesticide use and incidence of breast cancer in the California Teachers Study cohort |
Q39326953 | Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci |
Q46019480 | Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival. |
Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
Q37624504 | Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10 |
Q35749402 | Risk of second primary cancer in men with breast cancer |
Q38716934 | Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence |
Q33669034 | Role of primary tumor resection among chemotherapy-treated patients with synchronous stage IV colorectal cancer: a survival analysis |
Q33310470 | Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis |
Q44781581 | Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women |
Q38835179 | Sex differences in the association of cutaneous melanoma incidence rates and geographic ultraviolet light exposure |
Q36089391 | Shared genetics underlying epidemiological association between endometriosis and ovarian cancer |
Q61118451 | Shared heritability and functional enrichment across six solid cancers |
Q64004349 | Shared heritability and functional enrichment across six solid cancers |
Q37151786 | Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer |
Q37515856 | Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines |
Q34002907 | Socioeconomic Impacts on Survival Differ by Race/Ethnicity among Adolescents and Young Adults with Non-Hodgkin's Lymphoma |
Q37486453 | Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer |
Q30583547 | Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status |
Q37337219 | Survival after colorectal cancer diagnosis is associated with colorectal cancer family history |
Q46034086 | Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. |
Q46134121 | Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules |
Q33703793 | Survival of distinct Asian groups among colorectal cancer cases in California |
Q24806109 | The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer |
Q38461745 | The Cancer Genetics Network: recruitment results and pilot studies |
Q35268940 | The association between circulating total folate and folate vitamers with overall survival after postmenopausal breast cancer diagnosis |
Q50709318 | The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. |
Q35636609 | The association of body mass index with mortality in the California Teachers Study |
Q35558999 | The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort |
Q36836192 | The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial |
Q35024008 | The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing |
Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
Q43658255 | Timing of radiation therapy, lymph node retrieval, and survival in rectal cancer |
Q40782001 | Treatment for T1a Renal Cancer Substratified by Size: "Less is More". |
Q46080721 | Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ |
Q46289740 | Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis |
Q37081074 | Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium |
Q30766723 | Validation of family history data in cancer family registries |
Q31140446 | Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry |
Q36711004 | Validity of models for predicting BRCA1 and BRCA2 mutations |
Q56342454 | Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility |
Q33847791 | Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer |
Q35575288 | Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort |
Q41672358 | Young age as a prognostic factor in cervical cancer: results of a population-based study |
Q56334023 | rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology |
Search more.